Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Tax Provisions (2016 - 2025)

Surgery Partners' Tax Provisions history spans 12 years, with the latest figure at $13.6 million for Q4 2025.

  • For Q4 2025, Tax Provisions fell 88.74% year-over-year to $13.6 million; the TTM value through Dec 2025 reached $18.0 million, down 86.63%, while the annual FY2025 figure was $18.0 million, 86.63% down from the prior year.
  • Tax Provisions for Q4 2025 was $13.6 million at Surgery Partners, up from $5.5 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $120.8 million in Q4 2024 and bottomed at -$7.8 million in Q2 2023.
  • The 5-year median for Tax Provisions is $4.4 million (2024), against an average of $9.8 million.
  • The largest annual shift saw Tax Provisions plummeted 350.0% in 2021 before it surged 1913.33% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $11.8 million in 2021, then dropped by 16.1% to $9.9 million in 2022, then plummeted by 39.39% to $6.0 million in 2023, then soared by 1913.33% to $120.8 million in 2024, then tumbled by 88.74% to $13.6 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Tax Provisions are $13.6 million (Q4 2025), $5.5 million (Q3 2025), and -$1.1 million (Q2 2025).